Log in

NASDAQ:MDSOMedidata Solutions Stock Price, Forecast & News

Notice: This company has been marked as potentially delisted and may not be actively trading.
$92.22
0.00 (0.00 %)
(As of 10/28/2019)
Add
Compare
Today's Range
$92.21
Now: $92.22
$92.26
50-Day Range
$91.79
MA: $92.20
$92.25
52-Week Range
$60.10
Now: $92.22
$98.60
Volume7.30 million shs
Average Volume1.24 million shs
Market Capitalization$5.76 billion
P/E Ratio96.06
Dividend YieldN/A
Beta1.22
Medidata Solutions, Inc. provides cloud-based solutions for life sciences worldwide. It offers the Medidata Clinical Cloud, a platform, pioneering analytics, and clinical technology for the development and commercialization of new therapies. The company's platform solutions include data capture and management, and trial planning and management. It also provides professional services, such as implementation, sponsor enablement, strategic consulting, partner support, and e-learning and training. The company markets and sells its cloud-based solutions through a direct sales force and through relationships with channel and strategic partners. It serves pharmaceutical, biotechnology, medical device, and diagnostics companies; academic research centers, government, and other non-profit organizations; and other non-profit organizations; and contract research organizations and other entities engaged in clinical trials. The company was founded in 1999 and is headquartered in New York, New York.
Read More
Medidata Solutions logo

Beat the Market (BTM) Rank

Analyst Opinion: 1.0Community Rank: 2.7Dividend Strength: 0.0Insider Behavior: 1.0Valuation: 1.3 5 -4 -3 -2 -1 -

Overall Beat the Market Rank

1.19 out of 5 stars


Industry, Sector and Symbol

Industry Prepackaged software
Sub-IndustryHealth Care Technology
SectorMedical
Current SymbolNASDAQ:MDSO
CUSIP58471A10
Phone212-918-1800

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$635.70 million
Cash Flow$1.69 per share
Book Value$10.32 per share

Profitability

Net Income$51.92 million

Miscellaneous

Employees1,998
Market Cap$5.76 billion
Next Earnings DateN/A
OptionableOptionable

Receive MDSO News and Ratings via Email

Sign-up to receive the latest news and ratings for MDSO and its competitors with MarketBeat's FREE daily newsletter.

Medidata Solutions (NASDAQ:MDSO) Frequently Asked Questions

Do Wall Street analysts recommend investors buy shares of Medidata Solutions?

6 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Medidata Solutions in the last year. There are currently 6 hold ratings for the stock, resulting in a consensus recommendation of "Hold." View analyst ratings for Medidata Solutions.

How were Medidata Solutions' earnings last quarter?

Medidata Solutions Inc (NASDAQ:MDSO) posted its earnings results on Monday, July, 22nd. The company reported $0.48 earnings per share for the quarter, topping analysts' consensus estimates of $0.17 by $0.31. The firm had revenue of $180.50 million for the quarter, compared to the consensus estimate of $179.95 million. Medidata Solutions had a return on equity of 8.64% and a net margin of 6.43%. The business's revenue for the quarter was up 15.8% on a year-over-year basis. During the same quarter in the prior year, the business earned $0.43 EPS. View Medidata Solutions' earnings history.

What price target have analysts set for MDSO?

6 analysts have issued 12-month price targets for Medidata Solutions' shares. Their forecasts range from $92.25 to $92.25. On average, they anticipate Medidata Solutions' stock price to reach $92.25 in the next twelve months. This suggests a possible upside of 0.0% from the stock's current price. View analysts' price targets for Medidata Solutions.

Has Medidata Solutions been receiving favorable news coverage?

Media headlines about MDSO stock have trended negative on Wednesday, InfoTrie reports. The research group rates the sentiment of media coverage by reviewing more than six thousand news and blog sources. The firm ranks coverage of publicly-traded companies on a scale of negative five to positive five, with scores nearest to five being the most favorable. Medidata Solutions earned a news sentiment score of -2.8 on InfoTrie's scale. They also gave headlines about the company a news buzz of 0.0 out of 10, indicating that recent media coverage is extremely unlikely to have an impact on the company's share price in the next few days. View the latest news aboutMedidata Solutions.

Who are some of Medidata Solutions' key competitors?

What other stocks do shareholders of Medidata Solutions own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Medidata Solutions investors own include NVIDIA (NVDA), Applied Materials (AMAT), salesforce.com (CRM), Gilead Sciences (GILD), Allergan (AGN), Alibaba Group (BABA), GrubHub (GRUB), IBM (IBM), Western Digital (WDC) and BioMarin Pharmaceutical (BMRN).

Who are Medidata Solutions' key executives?

Medidata Solutions' management team includes the following people:
  • Mr. Tarek A. Sherif, Co-Founder, Chairman & CEO (Age 57)
  • Mr. Glen M. de Vries, Co-Founder, Pres & Director (Age 47)
  • Mr. Rouven Bergmann, Chief Financial Officer (Age 46)
  • Mr. Michael Pray, Exec. VP - Gen. Mang. of Global Sales (Age 53)
  • Ms. Jill Larsen, Exec. VP - HR & Chief HR Officer (Age 46)

What is Medidata Solutions' stock symbol?

Medidata Solutions trades on the NASDAQ under the ticker symbol "MDSO."

What is Medidata Solutions' stock price today?

One share of MDSO stock can currently be purchased for approximately $92.22.

How big of a company is Medidata Solutions?

Medidata Solutions has a market capitalization of $5.76 billion and generates $635.70 million in revenue each year. The company earns $51.92 million in net income (profit) each year or $0.96 on an earnings per share basis. Medidata Solutions employs 1,998 workers across the globe.

What is Medidata Solutions' official website?

The official website for Medidata Solutions is www.mdsol.com.

How can I contact Medidata Solutions?

Medidata Solutions' mailing address is 350 HUDSON ST. 9TH FLOOR, NEW YORK NY, 10014. The company can be reached via phone at 212-918-1800 or via email at [email protected]

This page was last updated on 5/27/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.